Evidence map›Paper›PMID 35917346›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors.

Yuzu Anazawa, Tomoki Kita, Rei Iguchi, Kumiko Hayashi, Shinsuke Niwa

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Joubert syndrome 26 protein enforces compartmentalized motility of a ciliary kinesin.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Kinesins inOpen biology · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Research progress of kinesin family in neurological diseases.Frontiers in cellular neuroscience · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuzu AnazawaGraduate School of Life Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan.ORCID 0000-0002-2025-6404
Tomoki KitaDepartment of Applied Physics, Graduate School of Engineering, Tohoku University, Sendai, Miyagi 980-8579, Japan.
Rei IguchiGraduate School of Life Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan.ORCID 0000-0002-6341-8805
Kumiko HayashiDepartment of Applied Physics, Graduate School of Engineering, Tohoku University, Sendai, Miyagi 980-8579, Japan.ORCID 0000-0002-2895-8945
Shinsuke NiwaGraduate School of Life Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan.ORCID 0000-0002-8367-9228
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

KIF1A is a kinesin superfamily motor protein that transports synaptic vesicle precursors in axons. Cargo binding stimulates the dimerization of KIF1A molecules to induce processive movement along microtubules. Mutations in human

Indexed as

Axonal TransportCaenorhabditis elegansKinesinsNeurodegenerative DiseasesSynaptic VesiclesAnimalsDisease Models, AnimalGenes, DominantHumansMotor ActivityMutationKIF1A protein, humanKinesinsaxonal transportKANDKIF1Akinesinsynaptic vesicles

Identifiers

PMID35917346
PMCPMC9371658
OpenAlexW4289520156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.